ATE390482T1 - Interleukin-1 hy2. mittel und verfahren - Google Patents

Interleukin-1 hy2. mittel und verfahren

Info

Publication number: ATE390482T1
Authority: AT; Austria
Prior art keywords: interleukin; methods; novel; nucleic acids; receptor antagonist
Prior art date: 1999-05-20

Application number

AT00937687T

Other languages

English (en)

Inventor

Dennis Ballinger

John Ford

Alice Ho

Hai Lin

Ann Pace

Original Assignee

Nuvelo Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-20

Filing date

2000-05-22

Publication date

2008-04-15

1999-05-20 Priority claimed from US09/316,081 external-priority patent/US6339141B1/en

2000-05-22 Application filed by Nuvelo Inc filed Critical Nuvelo Inc

2008-04-15 Application granted granted Critical

2008-04-15 Publication of ATE390482T1 publication Critical patent/ATE390482T1/de

Links

101001076386 Homo sapiens Interleukin-1 family member 10 Proteins 0.000 title 1
102100026015 Interleukin-1 family member 10 Human genes 0.000 title 1
102000039446 nucleic acids Human genes 0.000 abstract 2
108020004707 nucleic acids Proteins 0.000 abstract 2
150000007523 nucleic acids Chemical class 0.000 abstract 2
101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 abstract 1
229940119178 Interleukin 1 receptor antagonist Drugs 0.000 abstract 1
102000000589 Interleukin-1 Human genes 0.000 abstract 1
108010002352 Interleukin-1 Proteins 0.000 abstract 1
102000051628 Interleukin-1 receptor antagonist Human genes 0.000 abstract 1
239000003407 interleukin 1 receptor blocking agent Substances 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT00937687T 1999-05-20 2000-05-22 Interleukin-1 hy2. mittel und verfahren ATE390482T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/316,081 US6339141B1 (en)	1999-05-20	1999-05-20	Interleukin-1 Hy2 materials and methods
US09/522,964 US6372892B1 (en)	1999-05-20	2000-03-10	Interleukin—1 Hy2 materials and methods

Publications (1)

Publication Number	Publication Date
ATE390482T1 true ATE390482T1 (de)	2008-04-15

Family

ID=26980226

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00937687T ATE390482T1 (de)	1999-05-20	2000-05-22	Interleukin-1 hy2. mittel und verfahren

Country Status (6)

Country	Link
US (1)	US6365726B1 (de)
EP (1)	EP1179068B1 (de)
AT (1)	ATE390482T1 (de)
AU (1)	AU5282600A (de)
ES (1)	ES2300266T3 (de)
WO (1)	WO2000071719A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001042304A1 (en) *	1999-12-10	2001-06-14	Amgen, Inc.	Interleukin-1 receptor antagonist-related molecules and uses thereof
AU3115601A (en) *	2000-01-27	2001-08-07	Immunex Corporation	Fil-1 theta dnas and polypeptides
JP2004517619A (ja)	2000-12-21	2004-06-17	ノバルティスアクチエンゲゼルシャフト	インターロイキン−１関連遺伝子およびタンパク質
UA78516C2 (en) *	2001-08-10	2007-04-10	Applied Research Systems	Use of inhibitors of il-18 for treatment and/or prevention of hypersensitivity disorders, and in particular of delayed-type hypersensitivity
WO2006024038A2 (en) *	2004-08-27	2006-03-02	Codman & Shurtleff	Light-based implant for treating alzheimer’s disease
US7288108B2 (en) *	2005-03-14	2007-10-30	Codman & Shurtleff, Inc.	Red light implant for treating Parkinson's disease
USRE47266E1 (en)	2005-03-14	2019-03-05	DePuy Synthes Products, Inc.	Light-based implants for treating Alzheimer's disease
US20070032493A1 (en) *	2005-05-26	2007-02-08	Synta Pharmaceuticals Corp.	Method for treating B cell regulated autoimmune disorders
US7351253B2 (en) *	2005-06-16	2008-04-01	Codman & Shurtleff, Inc.	Intranasal red light probe for treating Alzheimer's disease
WO2007034465A2 (en) *	2005-09-21	2007-03-29	The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin	Use of il-1f5 for the modulation of an immune-mediated response
US7819907B2 (en) *	2005-10-31	2010-10-26	Codman & Shurtleff, Inc.	Device and method for fixing adjacent bone plates
HUE048024T2 (hu)	2006-08-10	2020-05-28	Roy C Levitt	Anakinra bronchiolitis obliterans szindróma kezelésében való alkalmazásra
US9320914B2 (en)	2008-03-03	2016-04-26	DePuy Synthes Products, Inc.	Endoscopic delivery of red/NIR light to the subventricular zone
US20100198316A1 (en) *	2009-02-04	2010-08-05	Richard Toselli	Intracranial Red Light Treatment Device For Chronic Pain
EP2851429B1 (de)	2012-05-18	2019-07-24	Adda Biotech Inc.	Protein und proteinkonjugate zur behandlung von diabetes und anwendungen davon
EP3400962A1 (de) *	2017-05-09	2018-11-14	Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V.	Inhibitoren von il-38 zur verwendung bei der behandlung und/oder prävention von krebs bei einem menschen
US10973908B1 (en)	2020-05-14	2021-04-13	David Gordon Bermudes	Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en)	2020-07-22	2026-01-27	David Gordon Bermudes	Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins
WO2023102605A1 (en) *	2021-12-07	2023-06-15	Monash University	Il-38 variants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2287254A1 (en) *	1997-04-21	1998-10-29	Schering Corporation	Mammalian cytokines; related reagents and methods
CA2326066A1 (en)	1998-04-03	1999-10-14	Hyseq, Inc.	A interleukin-1 receptor antagonist and uses thereof
WO2001042304A1 (en) *	1999-12-10	2001-06-14	Amgen, Inc.	Interleukin-1 receptor antagonist-related molecules and uses thereof

2000
- 2000-05-22 WO PCT/US2000/014144 patent/WO2000071719A1/en not_active Ceased
- 2000-05-22 EP EP00937687A patent/EP1179068B1/de not_active Expired - Lifetime
- 2000-05-22 AT AT00937687T patent/ATE390482T1/de not_active IP Right Cessation
- 2000-05-22 AU AU52826/00A patent/AU5282600A/en not_active Abandoned
- 2000-05-22 ES ES00937687T patent/ES2300266T3/es not_active Expired - Lifetime
- 2000-05-22 US US09/578,458 patent/US6365726B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU5282600A (en)	2000-12-12
WO2000071719A1 (en)	2000-11-30
US6365726B1 (en)	2002-04-02
WO2000071719A8 (en)	2001-06-21
ES2300266T3 (es)	2008-06-16
EP1179068B1 (de)	2008-03-26
EP1179068A1 (de)	2002-02-13

Legal Events

Date	Code	Title	Description
2008-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE390482T1 (de)	2008-04-15	Interleukin-1 hy2. mittel und verfahren
WO2003004529A3 (en)	2004-06-10	Ephrin-tie receptor materials and methods
CY2014038I2 (el)	2015-12-09	Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DE60106864D1 (de)	2004-12-09	Katalytisches Krackverfahren
WO2003054152A3 (en)	2004-12-16	Novel nucleic acids and polypeptides
WO2003025148A3 (en)	2004-11-25	Novel nucleic acids and polypeptides
WO2002070539A3 (en)	2003-11-20	Novel nucleic acids and polypeptides
WO2002081731A3 (en)	2004-08-05	Novel nucleic acids and polypeptides
DK1436309T3 (da)	2013-01-02	BGL3-beta-glukosidase og nukleinsyrer kodende derfor
NO20016243D0 (no)	2001-12-19	Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
WO2001075067A3 (en)	2002-04-04	Novel nucleic acids and polypeptides
WO2001057188A3 (en)	2002-02-28	Novel nucleic acids and polypeptides
WO2001057190A3 (en)	2006-11-16	Novel nucleic acids and polypeptides
WO2001066689A3 (en)	2002-05-30	Novel nucleic acids and polypeptides
WO2001088088A3 (en)	2002-10-31	Novel nucleic acids and polypeptides
WO2004080148A3 (en)	2005-03-31	Novel nucleic acids and polypeptides
WO2003029271A3 (en)	2003-11-20	Novel nucleic acids and polypeptides
ATE335481T1 (de)	2006-09-15	Zolpidem hemitartrat solvat
DK1930439T3 (da)	2011-08-29	Neurotrofe faktorer
WO2004087874A3 (en)	2005-12-22	Novel nucleic acids and polypeptides
ATE390485T1 (de)	2008-04-15	Irak-4 zusammensetzungen und deren verwendungen
WO2001079449A3 (en)	2002-03-28	Novel nucleic acids and polypeptides
IS7288A (is)	2004-06-21	Aðferðir til að hreinsa levófloxasín
WO2003000893A3 (en)	2003-10-02	Nucleic acids encoding g protein-coupled receptors
EP1446419A4 (de)	2007-05-23	Therapeutische polypeptide, für diese codierende nukleinsäuren und anwendungsverfahren